Lithium, when assessed as a marker on a Metabolomix+ panel using a First Morning Void (FMV) urine sample, offers valuable insights into an individual's metabolic status and nutritional balance. Lithium is a trace element commonly known for its role in psychiatric treatment, particularly in bipolar disorder. However, beyond its therapeutic applications, lithium plays a subtle yet significant role in various physiological processes. In the context of a Metabolomix+ panel, which evaluates a wide range of metabolic parameters, the concentration of lithium in urine can provide clues about an individual's dietary intake, as lithium is naturally found in some foods and drinking water. Moreover, emerging research suggests lithium's potential involvement in mood regulation, cognitive function, and neuroprotective processes. It's important to note that the urinary excretion levels of lithium can be influenced by various factors, including dietary habits, renal function, and the use of certain medications. Therefore, interpreting lithium levels in the context of a comprehensive metabolic panel such as Metabolomix+ requires careful consideration of the individual's overall health, diet, and medication use. This comprehensive approach ensures a more accurate assessment of an individual’s metabolic health and aids in tailoring personalized nutritional and therapeutic interventions.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.